Accentus Medical is widely recognized for its expertise in developing innovative surface treatments for medical implants and devices. Headquartered in the UK, the company supplies the majority of its products to international customers. Its proprietary coatings and surface modification technologies have delivered clinically proven outcomes over more than 20 years, improving the performance and longevity of orthopaedic implants.
With this acquisition, STS Group further strengthens its position as a total solution provider of surface technologies across multiple market sectors, including aerospace, oil & gas, energy, manufacturing, and now medical. Accentus Medical’s expertise will complement STS Group’s existing team of industry experts, enhancing the group’s ability to offer state-of-the-art surface engineering solutions to a broader customer base.
“The addition of Accentus Medical into the STS Group marks an important milestone in our growth strategy”, said Nathan Davies, CEO of STS Group. “Their expertise in medical coatings, combined with a leading reputation for product quality will facilitate our expansion into the healthcare sector, allowing us to provide innovative solutions that align with industry demands for high-performance, biocompatible coatings.”
“The Accentus Medical team is excited to join the STS Group”, said
Philip Agg, CTO of Accentus Medical. “The company will continue to operate under its established name while benefiting from STS Group’s global resources and infrastructure. The combined expertise and technological synergies of Accentus Medical and STS Group will drive innovation, production efficiency, and customer-focused solutions, as well as offer the opportunity to expand our global manufacturing footprint.”
The acquisition is backed by Batavorum Capital, an investment firm based in Nijmegen, Netherlands, that actively supports small and medium-sized enterprises in achieving their strategic objectives.
Batavorum Capital has been a key partner in STS Group’s expansion efforts and will continue to play a vital role in its future growth.
About the STS Group: STS Group is a leading global provider of Thermal Spray and Surface Engineering Technologies. It is comprised of two main divisions, being:
- Engineered Performance Coatings Ltd (EPC), which provides complete in-house coating services, including coating development and manufacturing of complete coated components.
- Flame Spray Technologies BV (FST) specializes in thermal spray equipment design and manufacture, engineered coating solutions, and distribution of consumables for surface engineering applications.
With operations in the United Kingdom, the Netherlands, and the United States, the company offers innovative solutions to a wide range of industries, including aerospace, oil & gas, energy, manufacturing, and medical.
For further information regarding this acquisition, please contact Nathan Davies (CEO, STS Group) – n.davies@sts-group.nl.